Chemotherapy Effects on Lungs | Medical Algorithm

Evaluation

Are you evaluating a patient undergoing induction chemotherapy for AML or high-risk myelodysplasia?

Yes

Gender of the patient

Male

Female

Does the patient have acute promyelocytic leukemia?

Yes

Did the chest X-ray at diagnosis show a pulmonary infiltrate?

Yes

Serum creatinine

Performance status

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for acute pulmonary failure present

The risk for the patient developing acute pulmonary failure is

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Risk Factors for Radiation-Induced Lung Injury
- Risk Factors for Interstitial Lung Disease Following Gefitinib Therapy
Clinical Diagnosis, Including Family History For Genetics
Complications
- Clinical Features of Diffuse Alveolar Hemorrhage (DAH)
- Clinical Features of Periengraftment Respiratory Distress Syndrome (PERDS)

Therapy

Interventional Radiology
- Equation and Nomogram for Predicting Radiation Pneumonitis

Monitoring

Adverse Effects

Specialty

Hematology Oncology
Pulmonology
Pharmacology, clinical

Objective

risk factors
adverse effects

ICD-10

T45.1 - Poisoning, antineoplastic and immunosuppressive drugs

Acute Myeloid Leukemia or High-Risk Myelodysplasia | Risk Factors for Acute Pulmonary Failure During Chemo

Purpose: To determine the risk for acute pulmonary failure developing in a patient undergoing induction chemotherapy for AML or myelodysplasia.